Table 3 Standardize mean differences of the change in serum lipids level from baseline (Alogloptin 25 mg vs control; Alogloptin 12.5 mg vs control), 2012

Lipid profile

Std. Mean Difference (95% CI)

I²

Number of included studies

Change in total cholesterol

−0.16 [−0.46, 0.15]

76%

4[22, 24–26]

Change in LDL-cholesterol

−0.05 [−0.27, 0.16]

53%

4[22, 24–26]

Change in HDL-cholesterol

−0.17 [−0.32, -0.02]

0%

4[22, 24–26]

Change in triglycerides

−0.14 [−0.33, 0.05]

39%

4[22, 24–26]

Alogliptin 12.5 mg treated vs control

Change in total cholestrol

−0.13 [−0.37, 0.10]

60%

4[22, 24–26]

Change in LDL-cholestrol

−0.10 [−0.25, 0.05]

0%

4[22, 24–26]

Change in HDL-cholesterol

−0.13 [−0.28, 0.02]

0%

4[22, 24–26]

Change in triglycerides

−0.06 [−0.29, 0.17]

58%

4[22, 24–26]